Skip to main content

Table 3 Subjects who fulfilled at least one of three conditions: a urinary β2-microglobulin (β2MG) level higher than 1000 μg/g cr., blood cadmium level higher than 6 μg/L, or urinary cadmium level higher than 10 μg/g cr., out of 22 subjects in Kosaka clinic in Kosaka town. The values of serum creatinine and urinary α1-microglobulin (α1MG) levels were also presented to support these data. They are listed in order of descending levels of urinary β2MG

From: Hospital-based screening to detect patients with cadmium nephropathy in cadmium-polluted areas in Japan

No.

Sex

Age

Serum creatinine (mg/dL)

Urinary α1MG (mg/g cr.)

Urinary ß2MG (μg/g cr.)

Blood cadmium (μg/L)

Urinary cadmium (μg/g cr.)

Medical history of diagnosed patients

1a

F

81

1.30

62.3

30,400

9.1

5.02

Hypertension, analgesic

2a

F

89

1.90

54.8

28,900

9.6

16.2

Hypertension

3a

F

75

0.98

43.3

14,800

13

5.23

Hypertension

4

M

84

1.29

34.9

8290

3.8

2.70

 

5

F

81

0.89

29.4

5390

2.2

ND

6

M

87

1.67

37.2

4960

6.1

ND

7

M

92

1.24

7.9

3940

2.5

ND

8

F

82

0.91

35.9

2770

6.9

8.01

9

M

83

1.25

8.3

2380

4.8

ND

10

M

80

1.46

26.5

1990

5.4

4.85

11

F

77

1.44

19.8

963

7.6

10.9

12

F

77

0.97

4.9

394

6.7

1.71

  1. F female, M male, ND not detected (less than 1.28 ng/mL as an original cadmium level)
  2. aDiagnosed with cadmium nephropathy